DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Norpace Cr is a drug marketed by Gd Searle Llc and is included in one NDA.
The generic ingredient in NORPACE CR is disopyramide phosphate. There are nineteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the disopyramide phosphate profile page.
A generic version of NORPACE CR was approved as disopyramide phosphate by TEVA on February 22nd, 1985.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Gd Searle Llc||NORPACE CR||disopyramide phosphate||CAPSULE, EXTENDED RELEASE;ORAL||018655-001||Jul 20, 1982||RX||Yes||No||Start Trial||Start Trial||Start Trial|
|Gd Searle Llc||NORPACE CR||disopyramide phosphate||CAPSULE, EXTENDED RELEASE;ORAL||018655-002||Jul 20, 1982||RX||Yes||Yes||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|